BIND

BIND Therapeutics Inc.

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

BIND price

BIND Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BIND

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals BIND

Valuation

P/E

0.00

Sector -3.53

Industry -3.53

P/BV

0.00

Sector 2.06

Industry 2.06

P/Revenue (PSR)

Sector 2.02

Industry 2.02

EV/EBITDA

Sector -222.67

Industry -222.67

EV/EBIT

Sector -47.57

Industry -47.57

P/EBITDA

Sector -21.45

Industry -21.45

P/EBIT

Sector -28.49

Industry -28.49

P/Total Assets

Sector 1.20

Industry 1.20

P/Net Current Assets

Sector -10.32

Industry -10.32

P/Working Capital

Sector -169.93

Industry -169.93

EPS

-1.04

Sector -1.79

Industry -1.79

BVPS

-0.16

Sector 2.05

Industry 2.05

Efficiency

Gross Margin

100.00%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-173.46%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-199.42%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.19

Sector 0.02

Industry 0.02

Profitability

ROE

647.05%

Sector -56.67%

Industry -56.67%

ROA

-92.53%

Sector -59.91%

Industry -59.91%

ROIC

Sector -2,349.21%

Industry -2,349.21%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.88

Industry 2.88

Net Debt / EBITDA

Sector -14,043,974.86

Industry -14,043,974.86

Net Debt / EBIT

Sector -8.02

Industry -8.02

Net Debt / Equity

Sector -32,936.86

Industry -32,936.86

Gross Debt / Equity

0.00

Sector -0.84

Industry -0.84

Equity/Assets

-0.14

Sector 0.46

Industry 0.46

Liabilities/Assets

1.14

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals BIND

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BIND BIND Therapeutics Inc.	$0.00	-	0.00%	0.00	0.00	647.05%	-100.00%
JNJ Johnson & Johnson	$270.22	55.95%	1.98%	30.47	7.54	24.76%	21.48%
PFE Pfizer Inc.	$27.64	23.02%	6.24%	35.93	1.84	5.11%	6.86%
ABBV AbbVie Inc.	$264.02	25.98%	2.65%	72.22	-76.87	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.69%	4.32%	10.50	5.58	53.11%	35.32%
MRK Merck & Co. Inc.	$147.15	88.54%	2.33%	112.32	8.48	7.55%	4.76%
AZN AstraZeneca PLC	$166.14	9.65%	2.03%	19.00	4.89	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.84	42.04%	3.96%	13.95	5.80	41.55%	18.85%
ZTS Zoetis Inc.	$73.02	-49.53%	2.89%	11.41	9.59	84.02%	27.77%
AMGN Amgen Inc.	$379.78	42.91%	2.25%	26.93	20.14	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$789.45	32.38%	0.47%	18.62	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$109.68	44.60%	0.00%	30.46	87.77	288.13%	24.86%
MCK McKesson Corporation	$879.57	27.49%	0.37%	19.68	-26.99	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$516.34	31.93%	0.00%	29.63	6.45	21.76%	35.00%
CAH Cardinal Health Inc.	$226.34	54.49%	0.88%	31.71	-20.07	-63.29%	0.68%
ARGX argenx SE	$995.77	32.36%	0.00%	2.61	3.00	114.60%	44.55%
HRMY Harmony Biosciences Holdings Inc.	$42.74	32.36%	0.00%	13.26	2.41	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BIND Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	08/26/2016	12/15/2016	0.38150000

ABOUT BIND Therapeutics

BIND Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

20 years

Founded: 2006

Time since IPO - - year

-

Employees

BIND Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $-3.35 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, BIND Therapeutics Inc. reported $14.85 million in revenue, generating net income of $-21.69 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BIND.

Market cap

Net worth

$-3.35 million

$-3,352,000.00

Assets

$23.44 million

$23,440,000.00

Total Shares Outstanding

20.88 million

20,884,000

Average Daily Trading Volume

$200.00

Sector

Health Care

Industry

Biotechnology

BIND

BIND revenue and profits

Financial Results BIND

DRAG THE FRAME TO SEE MORE DATA

BIND cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$879.57 28,10% (12M)

P/E

19.68

0.37%

ROE

-137.16%

P/BV

-26.99

CAH - Cardinal Health

$226.34 52,77% (12M)

P/E

31.71

0.88%

ROE

-63.29%

P/BV

-20.07

JNJ - Johnson & Johnson

$270.22 58,67% (12M)

P/E

30.47

1.98%

ROE

24.76%

P/BV

7.54

ABBV - AbbVie

$264.02 22,73% (12M)

P/E

72.22

2.65%

ROE

-106.44%

P/BV

-76.87

MRK - Merck & Co.

$147.15 87,53% (12M)

P/E

112.32

2.33%

ROE

7.55%

P/BV

8.48

AZN - AstraZeneca

$166.14 10,78% (12M)

P/E

19.00

2.03%

ROE

25.77%

P/BV

4.89

PFE - Pfizer

$27.64 22,51% (12M)

P/E

35.93

6.24%

ROE

5.11%

P/BV

1.84

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$879.57 28,10% (12 M)

P/L

19.68

0.37%

ROE

-137.16%

P/VP

-26.99

CAH - Cardinal Health

$226.34 52,77% (12 M)

P/L

31.71

0.88%

ROE

-63.29%

P/VP

-20.07

JNJ - Johnson & Johnson

$270.22 58,67% (12 M)

P/L

30.47

1.98%

ROE

24.76%

P/VP

7.54

ABBV - AbbVie

$264.02 22,73% (12 M)

P/L

72.22

2.65%

ROE

-106.44%

P/VP

-76.87

MRK - Merck & Co.

$147.15 87,53% (12 M)

P/L

112.32

2.33%

ROE

7.55%

P/VP

8.48

AZN - AstraZeneca

$166.14 10,78% (12 M)

P/L

19.00

2.03%

ROE

25.77%

P/VP

4.89

PFE - Pfizer

$27.64 22,51% (12 M)

P/L

35.93

6.24%

ROE

5.11%

P/VP

1.84

Frequently Asked Questions

What is the price of BIND Therapeutics (BIND) today?

A cotação de BIND Therapeutics (BIND) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de BIND Therapeutics (BIND) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de BIND Therapeutics (BIND) e dados de ações do Ibovespa e mercados internacionais.

Quando BIND Therapeutics (BIND) paga dividendos?

BIND Therapeutics (BIND) não distribuiu dividendos no último ano.

Is BIND Therapeutics (BIND) a good investment?

Atualmente, BIND Therapeutics (BIND) está cotada a US$ 0.00, com um P/L de 0.00, representando um desvio de 0% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy BIND Therapeutics (BIND) stock?

Investir em ações de BIND Therapeutics (BIND) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of BIND Therapeutics (BIND) yield today?

A rentabilidade de BIND Therapeutics (BIND) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de BIND Therapeutics (BIND) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BIND

BIND Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BIND

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING BIND WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT BIND Therapeutics

BIND Therapeutics Inc.

United States

20 years

-

Financial Results BIND

BIND cash flow

Asset, Revenue and Profit Growth - BIND

BIND balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions